Mercadal S, Ahn KW, Allbee-Johnson M, Ganguly S, et al. Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy. Haematologica 2024 Sep 5. doi: 10.3324/haematol.2024.285613.
PMID: 39234871